A paradox of hepatic insulin resistance is that, while the insulin-resistant liver fails to suppress gluconeogenesis—contributing to hyperglycemia—it often remains sensitive to insulin’s lipogenic effects, promoting de novo lipogenesis and hepatic steatosis. The gene discussed is INS; the disease is steatosis.